Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Complement activation in diabetes mellitus.

L Bergamaschini1, M Gardinali, M Poli

  • 1Istituto di Medicina Interna, Ospedale Maggiore, University of Milan, Italy.

Journal of Clinical & Laboratory Immunology
|July 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the psychosocial implications of general population screening for paediatric type 1 diabetes in Europe: Protocol for a mixed-methods study.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Metabolic, genetic and immunological features of relatives of type 1 diabetes patients with elevated insulin resistance.

Journal of endocrinological investigation·2024
Same author

The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.

Diabetes research and clinical practice·2021
Same author

Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.

Clinical and experimental immunology·2020
Same author

A complete flaccid quadriparesis as early presentation of Graves' disease.

Journal of endocrinological investigation·2019
Same author

Basal insulin therapy is associated with beneficial effects on postoperative infective complications, independently from circulating glucose levels in patients admitted for cardiac surgery.

Journal of clinical & translational endocrinology·2017
Same journal

Policy and science of FMD control: the stakeholders' contribution to decision making. A call for integrated animal disease management.

Journal of clinical & laboratory immunology·2006
Same journal

An informative case of Graves' disease with implications for schizophrenia.

Journal of clinical & laboratory immunology·2006
Same journal

Increase of circulating CD8+CD57+ lymphocytes after measles infection but not after measles vaccination.

Journal of clinical & laboratory immunology·2006
Same journal

Review: immunomodulatory activity of pregnancy-associated plasma protein-A.

Journal of clinical & laboratory immunology·2004
Same journal

Antibodies to Acinetobacter bacteria and bovine brain peptides, measured in bovine spongiform encephalopathy (BSE) in an attempt to develop an ante-mortem test.

Journal of clinical & laboratory immunology·2004
Same journal

Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy.

Journal of clinical & laboratory immunology·2004
See all related articles

Complement activation, indicated by elevated C4a levels, was observed in adult-onset diabetes mellitus patients. This finding was particularly pronounced in elderly individuals with vascular complications, suggesting a link between complement system and diabetes comorbidities.

Area of Science:

  • Immunology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a complex metabolic disorder with potential links to immune system dysregulation.
  • The complement system, a crucial part of innate immunity, plays a role in inflammation and host defense.
  • Understanding complement activation in diabetes may reveal new insights into disease pathogenesis and complications.

Purpose of the Study:

  • To investigate complement activation in patients with insulin-dependent (IDDM) and non-insulin-dependent (NIDDM) diabetes mellitus.
  • To compare plasma levels of complement components (C4, C3, C4a, C3a, SC5b-9) between diabetic patients and age-matched controls.
  • To explore correlations between complement activation and clinical factors such as disease duration, metabolic control, and vascular complications.

Main Methods:

Related Experiment Videos

  • Plasma concentrations of C4, C3, C4a, C3a, and SC5b-9 were measured in IDDM and NIDDM patients and control groups.
  • Patients were stratified by age of onset (juvenile vs. adult) and disease duration (≥2 years).
  • Statistical analyses were performed to compare complement levels and assess correlations with clinical parameters.

Main Results:

  • Plasma levels of C4, C3, and SC5b-9 did not significantly differ between diabetic patients and controls.
  • Significantly higher levels of the anaphylatoxin C4a were found in adult-onset IDDM patients compared to juvenile IDDM, NIDDM patients, and controls.
  • Elevated C4a levels were observed in elderly subjects, both diabetic and control, and were particularly pronounced in those with vascular complications.

Conclusions:

  • Complement activation, specifically indicated by increased C4a, is present in adult-onset diabetes mellitus.
  • Complement activation in diabetes does not appear to be directly correlated with metabolic control, disease duration, or autoantibody presence.
  • The findings suggest a potential role for complement activation in the development of vascular complications in elderly individuals, including those with diabetes.